Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study-Reference-Cited by-同舟云学术

Safety and effectiveness of a 12-week course of sofosbuvir and simeprevir ± ribavirin in HCV-infected patients with or without HIV infection: a multicentre observational study

Published:2017-03 Issue:3 Volume:49 Page:296-301
ISSN:0924-8579
Container-title:International Journal of Antimicrobial Agents
language:en
Short-container-title:International Journal of Antimicrobial Agents

Author:

Bruno Giuseppe,Saracino Annalisa,Fabrizio Claudia,Scudeller Luigia^ORCID,Milano Eugenio,Dell'Acqua Raffaele,Ladisa Nicoletta,Fasano Massimo,Minniti Salvatore,Buccoliero Giovanni,Tartaglia Alessandra,Giammario Adele,Milella Michele,Angarano Gioacchino^ORCID

Publisher

Elsevier BV

Subject

Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Medicine

Reference27 articles.

1. Natural history of hepatitis C;Westbrook;J Hepatol,2014

2. Newer therapeutics for hepatitis C;Poonia;Ann Transl Med,2016

3. Optimal therapy of HIV/HCV co-infected patients with direct acting antivirals;Rockstroh;Liver Int,2015

4. EASL recommendations on treatment of hepatitis C 2015;European Association for Study of Liver;J Hepatol,2015

5. Hepatitis C guidance: AASLD–IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus;AASLD/IDSA HCV Guidance Panel;Hepatology,2015

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Direct-acting antivirals for chronic Hepatitis C are effective and safe: an observational study in Londrina/PR;Brazilian Journal of Pharmaceutical Sciences;2022

2. International Liver Transplantation Society Asian Consensus on the Management of Hepatitis C Virus Infection in Resource Limited Setting—From Noncirrhotic to Decompensated Disease and After Liver Transplantation;Transplantation;2019-04

3. Treatment of HCV Infection with Direct-Acting Antiviral Agents in Patients with HIV/HCV Co-Infection: A Systematic Review;Hepatitis Monthly;2018-12-25

4. Effectiveness and safety of simeprevir-based regimens for hepatitis C in Italy;Medicine;2018-07

5. Adverse Effects of Direct Acting Antivirals in HIV/HCV Coinfected Patients: A 4-Year Experience in Miami, Florida;Diseases;2018-06-19